daily glp 1 agonist Glucagon-like peptide-1 receptor: mechanisms and advances in therapy and trans Researchers find GLP-1 medications safe

While injectable versions captured public and clinical attention with notable weight loss outcomes, oral options introduce a new level of convenience and patient accessibility

While genetic testing for variants linked to non response is not common, it represents the next step in helping ensure patients are given therapies that work better for them

What should I tell my Ro-affiliated provider before using Ozempic

These tests focus on four key elements, ensuring both safety and efficacy for our treatments

The LEADER CVOT trial found a higher incidence of DR-associated events in a group treated with liraglutide compared with placebo